2018
DOI: 10.1016/j.tmrv.2017.07.006
|View full text |Cite
|
Sign up to set email alerts
|

Exploring donor and product factors and their impact on red cell post-transfusion outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
49
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 39 publications
(51 citation statements)
references
References 105 publications
2
49
0
Order By: Relevance
“…Future studies will be necessary to investigate whether variables such as processing/storage additives may have masked the impact of age of blood on transfusion outcomes in recent randomized clinical trials. This study further stresses the opportunity to further improve standardization of blood product processing 42 and the formulation of storage additives. Finally, this study demonstrates the relevance of metabolomics technologies in transfusion medicine and the potential transformative impact that data generated through this technology can have when correlated with transfusion outcomes, as recommended by recent meetings on the state of science in transfusion medicine sponsored by the National Heart, Lung, and Blood Institute and the Food and Drug Administration.…”
Section: Resultsmentioning
confidence: 83%
See 2 more Smart Citations
“…Future studies will be necessary to investigate whether variables such as processing/storage additives may have masked the impact of age of blood on transfusion outcomes in recent randomized clinical trials. This study further stresses the opportunity to further improve standardization of blood product processing 42 and the formulation of storage additives. Finally, this study demonstrates the relevance of metabolomics technologies in transfusion medicine and the potential transformative impact that data generated through this technology can have when correlated with transfusion outcomes, as recommended by recent meetings on the state of science in transfusion medicine sponsored by the National Heart, Lung, and Blood Institute and the Food and Drug Administration.…”
Section: Resultsmentioning
confidence: 83%
“…This observation is relevant in the light of the increased awareness about the role of biological/processing variability across transfused units and their potential impact on transfusion outcomes. 42 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Of note, the association between the use of older RBCs and posttransplant mortality significantly changed after including fresh RBCs stored for less than 4 days (Fig. S3, available as supporting information in the online version of this paper), indicating the ease with which results can be distorted by key RBC product factors . Finally, an alloantibody test was routine for these units, ruling out the presence of an alloimmunization‐related event.…”
Section: Discussionmentioning
confidence: 99%
“…However, this method should be considered carefully after weighing the expected clinical benefit against the potential for a shortage of RBC products . Perioperative transfusion of fresh RBCs stored for less than 4 days was associated with increased mortality in immunosuppressed liver transplant recipients, in line with evidence demonstrating the risk of blood stored for a short duration . However, the use of old RBCs also carries potential risks because the structure of the RBCs and the biochemical characteristics of the storage medium change significantly after 2 weeks of cold storage, a condition termed the “RBC storage lesion.” Although such changes were found to be associated with vasoconstriction, coagulation disturbance, inflammation, and immunomodulation, the clinical relevance of these changes remains unclear.…”
mentioning
confidence: 99%